BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23927973)

  • 1. Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold.
    Bolton SA; Sutton JC; Anumula R; Bisacchi GS; Jacobson B; Slusarchyk WA; Treuner UD; Wu SC; Zhao G; Pi Z; Sheriff S; Smirk RA; Bisaha S; Cheney DL; Wei A; Schumacher WA; Hartl KS; Liu E; Zahler R; Seiler SM
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5239-43. PubMed ID: 23927973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors.
    Glunz PW; Zhang X; Zou Y; Delucca I; Nirschl AH; Cheng X; Weigelt CA; Cheney DL; Wei A; Anumula R; Luettgen JM; Rendina AR; Harpel M; Luo G; Knabb R; Wong PC; Wexler RR; Priestley ES
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5244-8. PubMed ID: 23845220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening.
    Cheney DL; Bozarth JM; Metzler WJ; Morin PE; Mueller L; Newitt JA; Nirschl AH; Rendina AR; Tamura JK; Wei A; Wen X; Wurtz NR; Seiffert DA; Wexler RR; Priestley ES
    J Med Chem; 2015 Mar; 58(6):2799-808. PubMed ID: 25764119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
    Zbinden KG; Obst-Sander U; Hilpert K; Kühne H; Banner DW; Böhm HJ; Stahl M; Ackermann J; Alig L; Weber L; Wessel HP; Riederer MA; Tschopp TB; Lavé T
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5344-52. PubMed ID: 16213138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral macrocyclic factor VIIa inhibitors.
    Wurtz NR; Parkhurst BL; DeLucca I; Glunz PW; Jiang W; Zhang X; Cheney DL; Bozarth JM; Rendina AR; Wei A; Harper T; Luettgen JM; Wu Y; Wong PC; Seiffert DA; Wexler RR; Priestley ES
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2650-2654. PubMed ID: 28460818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors.
    Priestley ES; Cheney DL; DeLucca I; Wei A; Luettgen JM; Rendina AR; Wong PC; Wexler RR
    J Med Chem; 2015 Aug; 58(15):6225-36. PubMed ID: 26151189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors.
    Glunz PW; Cheng X; Cheney DL; Weigelt CA; Wei A; Luettgen JM; Wong PC; Wexler RR; Priestley ES
    Bioorg Med Chem Lett; 2015; 25(10):2169-73. PubMed ID: 25881820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and synthesis of pyrazinones containing novel P1 'side pocket' moieties as inhibitors of TF/VIIa.
    Schweitzer BA; Neumann WL; Rahman HK; Kusturin CL; Sample KR; Poda GI; Kurumbail RG; Stevens AM; Stegeman RA; Stallings WC; South MS
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3006-11. PubMed ID: 15913999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
    Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4533-7. PubMed ID: 18674905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of a screening lead for factor VIIa/TF.
    Young WB; Kolesnikov A; Rai R; Sprengeler PA; Leahy EM; Shrader WD; Sangalang J; Burgess-Henry J; Spencer J; Elrod K; Cregar L
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2253-6. PubMed ID: 11527709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors.
    Groebke Zbinden K; Banner DW; Ackermann J; D'Arcy A; Kirchhofer D; Ji YH; Tschopp TB; Wallbaum S; Weber L
    Bioorg Med Chem Lett; 2005 Feb; 15(3):817-22. PubMed ID: 15664864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.
    Young WB; Mordenti J; Torkelson S; Shrader WD; Kolesnikov A; Rai R; Liu L; Hu H; Leahy EM; Green MJ; Sprengeler PA; Katz BA; Yu C; Janc JW; Elrod KC; Marzec UM; Hanson SR
    Bioorg Med Chem Lett; 2006 Apr; 16(7):2037-41. PubMed ID: 16412633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand.
    Choi-Sledeski YM; Kearney R; Poli G; Pauls H; Gardner C; Gong Y; Becker M; Davis R; Spada A; Liang G; Chu V; Brown K; Collussi D; Leadley R; Rebello S; Moxey P; Morgan S; Bentley R; Kasiewski C; Maignan S; Guilloteau JP; Mikol V
    J Med Chem; 2003 Feb; 46(5):681-4. PubMed ID: 12593648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors.
    Zhang X; Glunz PW; Jiang W; Schmitt A; Newman M; Barbera FA; Bozarth JM; Rendina AR; Wei A; Wen X; Rossi KA; Luettgen JM; Wong PC; Knabb RM; Wexler RR; Scott Priestley E
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1604-7. PubMed ID: 23416003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide exosite inhibitors of factor VIIa as anticoagulants.
    Dennis MS; Eigenbrot C; Skelton NJ; Ultsch MH; Santell L; Dwyer MA; O'Connell MP; Lazarus RA
    Nature; 2000 Mar; 404(6777):465-70. PubMed ID: 10761907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex.
    Zhang X; Glunz PW; Johnson JA; Jiang W; Jacutin-Porte S; Ladziata V; Zou Y; Phillips MS; Wurtz NR; Parkhurst B; Rendina AR; Harper TM; Cheney DL; Luettgen JM; Wong PC; Seiffert D; Wexler RR; Priestley ES
    J Med Chem; 2016 Aug; 59(15):7125-37. PubMed ID: 27455395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 5-azaindole factor VIIa inhibitors.
    Riggs JR; Hu H; Kolesnikov A; Leahy EM; Wesson KE; Shrader WD; Vijaykumar D; Wahl TA; Tong Z; Sprengeler PA; Green MJ; Yu C; Katz BA; Sanford E; Nguyen M; Cabuslay R; Young WB
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3197-200. PubMed ID: 16621549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.
    Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K
    Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.